WENCO-INTERNATIONAL
Wenco International Mining Systems Ltd. ("Wenco") is pleased to expand its sales and support to customers in Northern Europe through its new partnership with Rotator Oy, a leading provider of mining equipment and solutions, based in Finland.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220913006133/en/
This new agreement extends Wenco’s reach with a capable value-added reseller, paving the way for customers in the region to further leverage Wenco’s open and interoperable approach to mining technology.
Wenco is a leading provider of technology solutions to the global mining industry with a comprehensive suite of digital solutions that boost productivity, decrease operating costs, extend equipment life, enhance safety, and give mining companies actionable insights into their operations. Mines realize these benefits through systems for fleet management, machine guidance, safety, and asset health — all grounded in an open systems philosophy that empowers them to freely integrate systems to support their unique business processes, data requirements, and reporting needs.
“We’re very positive about the establishment of this partnership with Rotator,” says Andrew Pyne, President and CEO of Wenco. “They have a very strong presence in the region and an excellent track record of sales and support for Hitachi Construction Machinery, our parent company. We’re looking forward to working closely with Rotator to deliver value through the application of our technologies to their customers in the region.”
Rotator CEO Janne Wartiovaara concurs with Pyne. “We are excited to add Wenco to our Mining offering and look forward to bring more valuable solutions to our customers,” says Janne Wartiovaara.
In addition to solutions for fleet operations, Rotator and Wenco are introducing innovative fatigue management solutions to the market with Wenco’s SmartCap, the only technology proven to eliminate safety incidents caused by fatigue. SmartCap uses EEG to measure operator fatigue, then notify users of reduced ability to resist sleep — before a fatigue-related incident occurs.
Wenco and Rotator formed this partnership due to their shared focus on delivering customer-centric solutions to the mining industry. Founded in 1954, Rotator is one of the most experienced and well-established machine import and after-sales service companies in Finland. Located in Pirkkala with satellite offices in Vantaa, Kuopio, Seinäjoki, Oulu, Rovaniemi, Sotkamo, and Lieto, Rotator is committed to providing reliable, efficient, and safe solutions to customers through Finland and Sweden.
The company’s rich history of support for customers made it a natural partner for Wenco in Northern Europe.
Rotator is now in discussions with mines across Finland and Sweden on how they can advance their digital transformation with Wenco’s solutions. To learn more, please contact Rotator Sales Manager Sami Laitila at sami.laitila@rotator.fi or +35840-8242-495. For all other inquiries into Wenco and its solutions, please contact Wenco Regional Manager Europe, Middle East, and Kazakhstan, Klaus Hansson at khansson@wencomine.com or +971-522-600-596.
About Wenco International Mining Systems
For over 30 years, Wenco International Mining Systems has worked with mining companies to extract unrealized value. In support of this mission, Wenco has developed an integrated suite of solutions to support the digital transformation of the mining industry. Fleet management, asset health, fatigue management, and other technologies join together in the spirit of open interoperability to raise mine productivity and efficiency, lower routine costs, and establish a safe and smooth mining operation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220913006133/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom